News for hackers. Stuff that matters.
Re:The EpiPen, a Case Study in Health System Dysfunction by maxerickson on Saturday August 27, 2016 @12:59PM (#12373154)
The Hep C cure is an extremely valuable innovation.

I certainly hope that lots of people receive the cure in a rapid fashion, but I'm not sure that it really falls to the innovator to provide it to them.

(lots of payers (insurance and national healthcare systems) are paying high fees for it because it makes sense for them over the medium term to do so; it represents a cost savings)

As a society we should still probably seek cheaper ways of finding such cures, but it doesn't make a whole lot of sense to bemoan a new, better and cheaper treatment.

Re:The EpiPen, a Case Study in Health System Dysfunction by cheriot on Saturday August 27, 2016 @03:12PM (#12373703)
Did you see my original comment?

The point is to get the innovator payed in a way that justifies their investment AND help everyone that can be helped. I'm not bemoaning or blaming; the point is to design a better system. Right now paying the innovator requires limiting availability for no good reason.

Re:The EpiPen, a Case Study in Health System Dysfunction by ende on Sunday August 28, 2016 @10:37PM (#12379628)
I once saw someone propose an 'X-prize' style system of publicly funded incentive based competitions for medical device and pharma research. Interesting idea.